D-amphetamine challenge effects on Wisconsin Card Sort Test. Performance in schizotypal personality disorder

Schizophrenia Research

Volumn 20, Issue 1-2, 1996, Pages 29-32

  Siegel Jr , Benjamin V ^a   Trestman, Robert L ^a   O'Flaithbheartaigh, Séamus ^a   Mitropoulou, Vivian ^a   Amin, Farooq ^a   Kirrane, Richelle ^a   Silverman, Jeremy ^a   Schmeidler, James ^a   Keefe, Richard S E ^a   Siever, Larry J ^a,b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

amphetamine; schizophrenia; schizotypal personality disorder; Wisconsin Card Sort Test

Indexed keywords

DEXAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MENTAL TASK; ORAL DRUG ADMINISTRATION; PERSEVERATION; PERSONALITY DISORDER; PRIORITY JOURNAL;

EID: 0030152031     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(95)00002-X     Document Type: Article

References (13)

1. Daniel DG, Weinberger DR, Jones DW, Zigun JR, Coppola R, Handel S, Bigelow LB, Goldberg TE, Berman KF, Kleinman JE (1991) The effect of amphetamine on regional cerebral blood flow during cognitive activation in schizophrenia. J Neurosci 11, 1907-1917.
2. Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH (1987) Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry 44, 1008-1014.
3. Kahn RS, Harvey PD, Davidson M, Keefe RSE, Apter S, Neale JM, Mohs RC, Davis KL (1994) Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. Schizophr Res 11, 217-224.
4. Keefe RSE, Silverman JM, Amin F, Lees SE, Moskowitz J, Travaglini L, Harvey PD, Kahn R, Davidson M, Siever LJ, Mohs RC, Davis KL (1991) Frontal functioning and plasma HVA in the relatives of schizophrenic patients. Presented at the 30th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, PR, Dec. 9-13, 1991.
5. Keefe RSE, Silverman JM, Lees-Roitman S, Harvey PD, Duncan MA, Alroy D, Siever LJ, Davis KL, Mohs RC (1994) Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Res 53, 1-12.
6. Mathew RJ, Wilson WH (1989) Changes in cerebral blood flow and mental state after amphetamine challenge in schizophrenic patients. Neuropsychobiology 21, 117-123.
7. Mirsky AF, Lochhead SJ, Jones BP, Kugelmass S, Walsh D, Kendler KS (1992) On familial factors in the attentional deficit in schizophrenia: a review and report of two new subject samples. J Psychiat Res 26, 383-403.
8. Nuechterlein KH (1983) Signal detection in vigilance tasks and behavioral attributes among offspring of schizophrenic mothers and among hyperactive children. J Abnorm Psychol 92, 4-28.
9. Siever LJ, Kalus OF, Keefe RSE (1993) The boundaries of schizophrenia. Psychiat Clin North Am 16, 217-244.
10. Spitzer RL, Endicott J (1975) The schedule for affective disorders and schizophrenia (SADS). New York Biometrics Research, NY State Psychiatric Institute, New York.
11. Stangl D, Pfohl B, Zimmerman M, Bower W, Corenthal C (1985) A structured interview for the DSM III personality disorders. Arch Gen Psychiatry 42, 591-596.
12. Trestman RL, Keefe RSE, Mitropoulou V, Harvey PD, deVegvar ML, Losonczy MF, Lees-Roitman S, Davidson M, Aronson A, Silverman J, Siever LJ (1995) Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder 59, 127-136.
13. Weinberger DR, Berman KF, Illowsky BP (1988) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: III. A new cohort and evidence for a monoaminergic mechanism. Arch Gen Psychiatry 45, 609-615.